Invitation Accepted: Biopharma Leaders Will Testify At Senate Hearing On Pricing

 
• By Cathy Kelly

In addition to fielding tough questions about pricing practices at the session, executives may announce new voluntary efforts to lower drug costs and will offer their own ideas for legislation.

WASHINGTON - JULY 18: A sign at the entrance to a Senate Finance Committee hearing room in Washington, DC on July 18, 2017. The United States Senate is the upper chamber of the United States Congress.

More from Pricing Debate

More from Market Access